RAC

1.74%

$1.47 race oncology ltd

RAC Upside - promising forgotten cancer drug that works, page-199

First 199 Last

Share
Profile

Follow
Mason14

1,258 Posts.

12380

13/03/21

15:22

Post #: 51743868
Share
Originally posted by wombat777: ↑

DYOR. This comparative analysis is not intended as financial advice. You are encouraged to do your own research and make your own investment decisions. Disclosures - held, sentiment bullish/long. This is my own analysis and I have not received compensation for it.
Update to my analysis. I've re-ordered the content to cover the fundamentals in a more logical sequence. I have also tried to make more key points about the investment thesis on each page.

View attachment 3005023

I will periodically update as new information comes in. The buyout valuation figures oscillate with the movements in the exchange rate. That's why the figures can vary from one edition to the next.
Enjoy!

The more investors and potential investors that understand:
the compelling clinical maturity and what this means from probability of success; and
the strong buyout transactions achieved for cancer Biotechs
the greater the chance that RACE and Bisantrene will be bought out for fair value.

Using conservative assumptions, risked NPV is currently USD $11.67B which would be a buyout at $75 per share.

View attachment 3004997

Expand

Outstanding work!
RAC Price at posting: $4.00 Sentiment: None Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

What each US election outcome would mean for Australian companies & investors

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

There are more pages in this discussion • 10 more messages in this thread...

First 199 Last

Add RAC (ASX) to my watchlist

(20min delay)
Last $1.47		Change 0.025(1.74%)		Mkt cap ! $249.7M

Open	High	Low	Value	Volume
$1.44	$1.48	$1.44	$25.63K	17.46K

Buyers (Bids)

No.	Vol.	Price($)
1	312	$1.47

Sellers (Offers)

Price($)	Vol.	No.
$1.48	354	1

View Market Depth

No.	Vol.	Price($)
1	312	1.465
1	2000	1.460
1	548	1.440
1	2046	1.420
3	14000	1.410

Price($)	Vol.	No.
1.480	11014	1
1.495	2500	1
1.500	4999	1
1.520	485	1
1.530	10000	1

Last trade - 16.10pm 01/11/2024 (20 minute delay)

RAC (ASX) Chart

RAC Upside - promising forgotten cancer drug that works, page-199

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

What each US election outcome would mean for Australian companies & investors

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RAC Upside - promising forgotten cancer drug that works, page-199

Top Stories

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

What each US election outcome would mean for Australian companies & investors

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Making money: How many microcaps should be in an investor's portfolio?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News